drugset / Trial / NCT01960283
Methotrexate in the Treatment of Chronic Idiopathic Urticaria
RandomizedParallel-groupDouble-blindTreatment
Summary
Chronic urticaria is defined by urticarial lesions persisting at 6 weeks. The cause is not found in about 75% of cases (chronic idiopathic urticaria). The gold standard treatment consists of anti-H1 molecules. In severe cases, refractory to anti-H1, few therapeutic alternatives exist. Methotrexate, which is not expensive and often prescribed by dermatologists, has been efficiently tried in an open study on severe chronic idiopathic urticaria, and also in few case reports.
Timeline
- Start
- 2011-11
- Primary completion
- 2016-03
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methotrexate | Small molecule | 0.25 mg/kg | Oral |